Johnson & Johnson, Imerys Talc Move for Directed Verdict at Conclusion of Plaintiffs’ Evidence in Talc-Based Powder Trial

ST. LOUIS –– Johnson & Johnson and Imerys Talc America Inc. have moved for a directed verdict at the close of the plaintiffs’ evidence in a talcum powder ovarian cancer trial, according to the court’s online docket.

The Johnson & Johnson and Imerys Talc defendants filed the motion on April 21 and 22 in the Missouri Circuit Court for St. Louis City, shortly after plaintiff Gloria Ristesund concluded her case.

Defendant Imerys Talc began presenting its case on April 21, according to the court docket. As of April 25, the defendant was still presenting evidence on its own …